Sevoflurane vs. Propofol for General Anesthesia in Patients With Acute Ischemic Stroke Treated With Endovascular Therapy

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 314 participants.

Also called NCT07902791

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 314 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07902791
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07902791. Randomized; single masking; primary purpose treatment. Start 2026-06-22 (actual); primary completion 2029-03-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sevoflurane vs. Propofol for General Anesthesia in Patients With Acute Ischemic Stroke Treated With Endovascular Therapy
Acronym
SAVE
Condition
Acute Ischemic Stroke
Condition
Large Vessel Occlusion
Intervention (Drug)
Sevoflurane
Intervention (Drug)
propofol (drug)
Lead sponsor
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (class: other)

Record details

Record id
cardio:ct-nct07902791
Content hash
18692bd24e9aff1d3a7674fd3ccddc09184bd4c458a00fec21212ec57c66b162